Sigma-Aldrich Protein Delivery System Human Tgf#Eta &

Protein delivery system, Human TGF-β2, PODS contains the polyhedrin protein co-crystalized with Human TGF-β2. Transforming Growth Factors (TGFs) are multifunctional peptides that regulate growth and differentiation in most cell types. The TGF-β family of proteins signal through serine/threonine kinase receptors. TGF-β isoforms (TGF-β1, -β2, and -β3) have overlapping, yet distinct biological actions in developing and adult tissues. TGF-β2 demonstrates cross-species reactivity. TGF-β2 may have an autocrine function in enhancing tumour growth by supressing immunosurveillance of tumour development.

PODS are composed of a bioactive cargo protein within a polyhedrin crystal lattice, with polyhedrin as the main protein. The 25 µg SKU size indicates the amount of bioactive cargo, typically 0.5% to 5% of the total protein. For instance, a 25 µg SKU at a 2% cargo loading contains 1.25 mg of total protein. PODS enable sustained release of cargo proteins when proteases degrade the polyhedrin scaffold. Growth factors are not bioavailable until released, and their concentration in media depends on the amount added and the release rate. In 10% serum, peak levels are usually reached within 24-48 hours, with about 20% of the cargo becoming soluble.

PODS often require lower concentrations than conventional growth factors, as they maintain effective levels. Pre-incubating with serum or proteases enhances availability, while conventional factors can be added for immediate effects. Optimal amounts should be determined empirically.

PODS is a registered trademark of Cell Guidance Systems Ltd